Comerica Bank
XLRN

Comerica Bank’s Acceleron Pharma XLRN Stock Holding History

Comerica Bank’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-68,532
Closed -$11.9M – 2239
2021
Q3 		$11.9M Sell
68,532
-2,296
-3% -$300K 0.07% 284
2021
Q2 		$8.5M Buy
70,828
+20,331
+40% +$2.56M 0.05% 421
2021
Q1 		$6.17M Buy
50,497
+14,909
+42% +$1.93M 0.04% 614
2020
Q4 		$4.43M Buy
35,588
+18,404
+107% +$2.16M 0.03% 775
2020
Q3 		$1.88M Buy
17,184
+6,970
+68% +$694K 0.01% 1166
2020
Q2 		$1.08M Sell
10,214
-1,658
-14% -$160K 0.01% 1456
2020
Q1 		$1.18M Sell
11,872
-9,159
-44% -$712K 0.01% 1238
2019
Q4 		$1.81M Sell
21,031
-3,453
-14% -$157K 0.01% 1197
2019
Q3 		$1.03M Sell
24,484
-1,095
-4% -$47.5K 0.01% 1510
2019
Q2 		$1.07M Sell
25,579
-2,390
-9% -$99K 0.01% 1493
2019
Q1 		$1.25M Buy
27,969
+3,600
+15% +$158K 0.01% 1444
2018
Q4 		$964K Buy
24,369
+290
+1% +$14.5K 0.01% 1567
2018
Q3 		$1.22M Buy
+24,079
New +$1.18M 0.01% 1474

Comerica Bank's XLRN Position: Q4 2021 in Review

Comerica Bank sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 68,532 shares — an estimated $11.9M sold.

Comerica Bank first reported a position in XLRN in Q3 2018 and held it in 13 quarters. The position peaked at $11.9M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Comerica Bank reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Comerica Bank sold 68,532 Acceleron Pharma shares in Q4 2021, an estimated $11.9M.
  • Comerica Bank first reported a position in Acceleron Pharma in Q3 2018 and held it in 13 quarters.
  • Comerica Bank's Acceleron Pharma position peaked at $11.9M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Comerica Bank's 13F filing for Q4 2021, filed 18 Feb 2022.